Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 16/20 | 0.55 |
| ▸ | PPARD | Q03181 | 13/20 | 0.55 |
| ▸ | PPARG | P37231 | 10/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL3450110 | 0.97 | FFAR1 (0.53) | FFAR1PPARDPPARG | |
| SCHEMBL3450111 | 0.89 | FFAR1 (0.45) | FFAR1PPARDPPARG | |
| SCHEMBL5624535 | 0.75 | FFAR1 (0.64) | FFAR1PPARDPPARG | |
| SCHEMBL13068481 | 0.73 | PPARG (0.73) | FFAR1PPARDPPARG | |
| SCHEMBL3449394 | 0.71 | FFAR1 (0.65) | FFAR1PPARDPPARG | |
| SCHEMBL25846076 | 0.71 | FFAR1 (0.56) | FFAR1PPARDPPARG | |
| SCHEMBL25846438 | 0.71 | FFAR1 (0.56) | FFAR1PPARDPPARG | |
| SCHEMBL3451902 | 0.71 | FFAR1 (0.67) | FFAR1PPARDPPARG | |
| SCHEMBL206775 | 0.71 | PPARD (0.69) | FFAR1PPARDPPARG | |
| SCHEMBL10011429 | 0.70 | PPARD (0.62) | FFAR1PPARDPPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7820837-B2 | ethyl {6-[(3-phenoxybenzyl)oxy]-3,4-dihydronaphthalen-1-yl}acetate; having a GPR40 receptor function modulating action and being useful as an insulin secretagogue or a pharmaceutical agent for the prophylaxis or treatment of diabetes | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-10-26 | — | — | US | disclosed |
| US-7820837-B2 | ethyl {6-[(3-phenoxybenzyl)oxy]-3,4-dihydronaphthalen-1-yl}acetate; having a GPR40 receptor function modulating action and being useful as an insulin secretagogue or a pharmaceutical agent for the prophylaxis or treatment of diabetes | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-10-26 | — | — | US | disclosed |